Posted by Michael Wonder on 24 Mar 2020
Updates from Lilly about insulin supply and affordability
24 March 2020 - To keep the diabetes community informed about important developments from the COVID-19 crisis, Eli Lilly today is providing updates related to insulin supply and affordability.
As we announced on March 3, Lilly does not currently anticipate shortages for any of our medicines, including all forms of insulin. Lilly is committed to manufacturing medicines that meet global safety, quality, value and environmental expectations.
With the help of a large network of global external manufacturing partners we supply medication to nearly 125 countries. Lilly is committed to public health and the needs of people with chronic conditions who depend on our medicines around the world.
